This medical and educational podcast was supported by Bristol Myers Squibb.
The EMJ Podcast | Bonus Episode
George Cooper is joined by Perry Elliott, Professor of Cardiovascular Medicine at University College London, UK, and Anjali Owens, Associate Professor of Medicine in the Division of Cardiology at the Perelman School of Medicine of the University of Pennsylvania, USA. Following an incredible symposium session at the 2024 European Society of Cardiology (ESC) Congress, they discuss case studies and real-world evidence relating to hypertrophic cardiomyopathy and the use of mavacamten.
Spotify | Apple | Amazon Music | Download MP3 (32:35 mins)
Speaker bio:
Professor Perry Elliott
Professor Elliott leads the UCL Centre for Heart Muscle Disease and heads the Inherited Cardiovascular Disease Unit at Bart’s Heart Centre in London, UK.
He studied medicine at St. Thomas’s Hospital Medical School in London, qualifying in 1987. He then trained in general medicine and became a member of the Royal College of Physicians, UK, in 1991. He completed his cardiology training at St. George’s Hospital Medical School and, in 1999, was appointed Senior Lecturer at St. George’s. In 2003, he joined UCL in the same role, later becoming Reader in Inherited Cardiac Disease in 2005 and achieving full professorship in 2012.
Professor Elliott was elected a Fellow of the European Society of Cardiology (ESC) in 2005 and has since held various leadership roles, including past Chair of the ESC Working Group on Myocardial and Pericardial Diseases (2010–2012) and Chair of the ESC Guideline Task Force on Hypertrophic Cardiomyopathy. He also leads the cardiovascular department for the North Thames NHS Genomic Medicine Centre and serves as President of Cardiomyopathy UK, a leading European charity supporting patients with heart muscle diseases. He has also contributed to academic publishing, having been Deputy Editor for The Heart Journal (2009–2013) and currently holding the same role for the International Journal of Cardiology.
With a career spanning over 25 years, Professor Elliott has built a global reputation in heart muscle disease research, publishing over 400 peer-reviewed papers.
Dr Anjali Owens
Dr Owens is an Associate Professor of Medicine at the Perelman School of Medicine, University of Pennsylvania, and serves in the Division of Cardiology at the Hospital of the University of Pennsylvania, USA. She completed her undergraduate and medical degrees at Duke University before pursuing her internship, residency, and chief medical residency at the Hospital of the University of Pennsylvania. She then completed specialised fellowships in both heart failure and transplantation, as well as cardiovascular medicine, at the same institution. In addition, she earned a Clinical Research Certificate from the Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania.
Dr Owens is the Founding Director of the Penn Familial Cardiomyopathy Program, where she has pioneered efforts in genetic cardiomyopathies, and also directs the Hypertrophic Cardiomyopathy Clinic, providing advanced care for patients with this inherited condition. In 2015, she was appointed Medical Director of the Penn Center for Inherited Cardiovascular Disease, where she continues to lead clinical and research efforts in the diagnosis and treatment of inherited heart diseases.
Her work focuses on bridging clinical care and genetic research, with a strong emphasis on the translation of genetic data into actionable medical treatments for patients and families affected by cardiomyopathies. Dr Owens has been on the faculty of Penn’s Heart Failure and Transplantation Program since 2011, playing a key role in advancing patient care and research in cardiovascular genetics.
